Wong Cindy Siaw Lin, Krishnan Arya, Kumaran Naren, Tanner Nicola
Department of General Surgery, Northampton General Hospital NHS Trust, Cliftonville, Northamptonshire, NN15BD, UK.
Surg Endosc. 2025 Mar;39(3):1653-1660. doi: 10.1007/s00464-024-11510-6. Epub 2025 Jan 9.
Endoscopic retrograde cholangiopancreatography (ERCP) has become the gold standard management for patients who present with common bile duct stone (CBDS). Although laparoscopic cholecystectomy is generally recommended for patients who have CBDS clearance, there is still a significant proportion of patients who are managed expectantly. Our study aimed to evaluate the outcomes of expectant management (EM) versus prophylactic cholecystectomy after initial endoscopic removal of CBDS.
We performed a retrospective review of all patients who underwent ERCP for choledocholithiasis from 1st January 2017 to 31st December 2019. Patients were further classified into young or elderly group using age 60 years as the cut-off. Primary outcomes measured biliary-related complications in each interventional group whereas secondary outcomes measured all-cause mortality.
136 patients (51.3%) had EM whereas 129 patients (48.7%) were initially planned for LC. There was 20.6% of recurrence of biliary events in EM group as compared to 3.9% in LC group. The median time from first ERCP to recurrence of biliary events in the EM group was 14 months. Overall complications of LC group was low (5.4%) with nil operative-related mortality. However, there was a significant higher proportion of elderly patients in EM group in comparison to LC group (88.2% vs 31%) and 51.4% of EM group died during follow-up period with only one biliary-related death.
Prophylactic cholecystectomy should be recommended for patients who have undergone ERCP clearance of CBDS. A watch-and-wait approach may be justified for elderly populations who are not ideal surgical candidates and a follow-up duration of up to 2 years is recommended.
内镜逆行胰胆管造影术(ERCP)已成为胆总管结石(CBDS)患者的金标准治疗方法。虽然一般建议对已清除CBDS的患者进行腹腔镜胆囊切除术,但仍有相当一部分患者接受保守治疗。我们的研究旨在评估首次内镜下清除CBDS后保守治疗(EM)与预防性胆囊切除术的效果。
我们对2017年1月1日至2019年12月31日期间因胆总管结石接受ERCP的所有患者进行了回顾性研究。以60岁为界,将患者进一步分为青年组或老年组。主要结局指标为各干预组的胆道相关并发症,次要结局指标为全因死亡率。
136例患者(51.3%)接受了EM,而129例患者(48.7%)最初计划行LC。EM组胆道事件复发率为20.6%,而LC组为3.9%。EM组从首次ERCP到胆道事件复发的中位时间为14个月。LC组的总体并发症发生率较低(5.4%),无手术相关死亡。然而,与LC组相比,EM组老年患者的比例显著更高(88.2%对31%),51.4%的EM组患者在随访期间死亡,其中只有1例与胆道相关。
对于已接受ERCP清除CBDS的患者,应建议进行预防性胆囊切除术。对于不适合手术的老年人群,观察等待的方法可能是合理的,建议随访时间长达2年。